Adjunctive Glycine for Obsessive Compulsive Disorder

Completed · Not applicable · Has a placebo group

Conditions studied: Obsessive Compulsive Disorder

In brief

The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.

Key facts

Study ID

NCT00405535

Run by

Nathan Kline Institute for Psychiatric Research

People needed

24

Starts

2004-06-01

Expected to finish

2006-12-01

Last updated by the study team

2016-12-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of OCD present for at least 1 year
• Male or female, age 18 to 65
• Stable medication regimen for 12 weeks prior to study entry
• at least moderately severe OC symptoms

You may not qualify if…

• Active substance use disorder within the last 6 months
• Comorbid schizophrenia, schizoaffective disorder, bipolar disorder, tic disorder, Tourette Disorder, schizotypal personality disorder
• Hoarding as the principal OCD symptom
• Insulin-dependent diabetes mellitus
• Pregnant or breastfeeding

Where it is running

• The Nathan Kline Institute for Psychiatric Research — Orangeburg, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.